Tue.Aug 02, 2022

Remove category
article thumbnail

Unpacking Averages: Assessing Whether FDA’s Breakthrough Device Designation Is Helpful

Health Law Advisor

My goal in nearly every device submission is to try to get through the FDA process with as little attention from FDA as possible. But when a seasoned person looks at it who has experience with FDA, their first thought is, do I really want FDA more involved in the process? Free advice! That’s not a criticism.

FDA 52
article thumbnail

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

Health Populi

In the meantime, the FDA has received at least 2 million adverse events each year since 2018, which contribute to less-optimal patient outcomes — or, in the worst cases, deaths. For patients to fully engaged with medicines in their treatment and self-care, trust must be embedded across these three categories (and others along the way).